Navigation Links


discuss at medicine technology

Cell Therapeutics, Inc. Management to Discuss Today's Announcement of Interim Pixantrone Study Results

SEATTLE, July 11, 2007 /PRNewswire-FirstCall/ -- On Wednesday,July 11, 2007, at 1:30 p.m. Pacific/4:30 p.m. Eastern/10:30 p.m.Central European Time members of Cell Therapeutics, Inc.'s (CTI)management team will host a conference call to discuss today'sannouncement of the interim results of its phase II/III RAPID trialcomparing CHOP-R to CPOP-R, in which pixantrone is substituted fordoxor...

Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycin's First of Two Phase 3 Pneumonia Trials

CHICAGO, June 29, 2007 /PRNewswire-FirstCall/ -- Advanced LifeSciences Holdings, Inc. , today announced that it will host aconference call and live webcast at 10:00 am (EDT) on Monday, July2, 2007 to discuss data from Trial CL-06, the first of two pivotalPhase 3 clinical trials designed to assess the safety andeffectiveness of cethromycin, a novel once-a-day antibiotic, forthe treatment...

Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimer's Disease Study

SAN FRANCISCO, June 05, 2007 /PRNewswire-FirstCall/ --Medivation, Inc. today announced that it will hold a teleconferenceat 8:30 a.m. Eastern time on Monday, June 11, to discuss top-line12-month results from its randomized, double-blind,placebo-controlled Phase 2 clinical trial of Dimebon(TM), its leadproduct candidate, in Alzheimer's disease. Rachelle Doody, M.D., Ph.D., lead inve...

Clinical Trial Results Change Standard of Care for Pancreatic Cancer Patients, Future Therapies Discussed

CHICAGO, June 05, 2007 /PRNewswire-USNewswire/ -- The BarbaraAnn Karmanos Cancer Institute's Philip A. Philip, M.D., Ph.D.F.R.C.P., professor of medicine and oncology, presented the outcomeof one of the largest randomized phase III pancreas cancer clinicaltrials in North America and chaired an education session about thefuture of pancreatic cancer therapies at the American Society ofClin...

2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion

REGENSBURG, Germany, May 10th, 2007 - AntisensePharma, a German biopharmaceutical company specialized in targetedtherapies for malignant tumors, today announced, that data from thePhase IIb-study with AP 12009 in high-grade glioma will bepresented at the 43rd Annual Meeting of the American Society ofClinical Oncology (ASCO), which will be held in Chicago, Illinois,U.S.A, fro...

Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention

BOTHELL, Wash., April 18, 2007 /PRNewswire-FirstCall/ -- HelixBioMedix, Inc. today announced that Timothy Falla, Ph.D, ChiefScientific Officer, will present an update on the company's newgeneration of small molecule peptide (lipohexapeptide) technologyat the BIO International Convention. The convention will take placeat the Boston Convention & Exhibition Center in Boston, MA fromMay...
Other TagsDysfunctionPrisonerOverdoseiGATEiGATE
(Date:8/28/2008)... , Quicker microwave meals that use less energy m...hes and, according to the material scientists resp...c waste remediation. , , "Currently, food heate...se the dishes are transparent to microwaves," says...y mineralogy, College of Agricultural Sciences at ...
(Date:8/28/2008)... , Researchers at The University of Nottingham ha...to develop a new drug that could ease the sufferin...ts who are unable to take beta-blockers. , In th... and most are able to have their symptoms effectiv...drugs which stop adrenaline from making the heart ...
(Date:8/28/2008)... , BIRMINGHAM, Ala. -- Intravenous magnesium su... the risk for handicapping cerebral palsy in half,...a at Birmingham (UAB) obstetrician Dwight Rouse, M...w England Journal of Medicine. , Cerebral palsy...ting control of movement and posture and limiting ...
(Date:8/27/2008)... ,, DALLAS Aug. 28, 2008 Researchers at UT...ce that the brain must create new nerve cells for ...ssion-like behavior. , In addition, the research...e same biochemical pathway to exert their effects.... mechanisms of antidepressants and provide a new d...
Breaking Biology News(10 mins):Ceramic material revs up microwaving 2New beta-blocker to offer hope to heart and lung sufferers 2Common treatment to delay labor decreases preterm infants' risk for cerebral palsy 2Common treatment to delay labor decreases preterm infants' risk for cerebral palsy 3Antidepressants need new nerve cells to be effective, UT Southwestern researchers find 2Why do astronauts suffer from space sickness 3F 20003 1Why do astronauts suffer from space sickness 3F 20003 2Lilly Announces Changes in Key Leadership Roles 20000 1Lilly Announces Changes in Key Leadership Roles 20000 2Lilly Announces Changes in Key Leadership Roles 20000 3Lilly Announces Changes in Key Leadership Roles 20000 4Lilly Announces Changes in Key Leadership Roles 20000 5VA Secretary Appoints Panel of National Suicide Experts 19997 1VA Secretary Appoints Panel of National Suicide Experts 19997 2 C O R R E C T I O N Rosetta Genomics Ltd 5557 1 C O R R E C T I O N Rosetta Genomics Ltd 5557 2 C O R R E C T I O N Rosetta Genomics Ltd 5557 3 C O R R E C T I O N Rosetta Genomics Ltd 5557 4 C O R R E C T I O N Rosetta Genomics Ltd 5557 5 C O R R E C T I O N Rosetta Genomics Ltd 5557 6 C O R R E C T I O N Rosetta Genomics Ltd 5557 7 C O R R E C T I O N Rosetta Genomics Ltd 5557 8 C O R R E C T I O N Rosetta Genomics Ltd 5557 9 C O R R E C T I O N Rosetta Genomics Ltd 5557 10 C O R R E C T I O N Rosetta Genomics Ltd 5557 11 C O R R E C T I O N Rosetta Genomics Ltd 5557 12 C O R R E C T I O N Rosetta Genomics Ltd 5557 13 C O R R E C T I O N Rosetta Genomics Ltd 5557 14 C O R R E C T I O N Rosetta Genomics Ltd 5557 15 C O R R E C T I O N Rosetta Genomics Ltd 5557 16 C O R R E C T I O N Rosetta Genomics Ltd 5557 17 C O R R E C T I O N Rosetta Genomics Ltd 5557 18 C O R R E C T I O N Rosetta Genomics Ltd 5557 19 C O R R E C T I O N Rosetta Genomics Ltd 5557 20
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
Other Contentsorbitalorbitalorbitalorbitalorchiectomyorchitisorgasmorgasmorthopaedicsorganicorganicorganicorganicorganicorganicorganicorganicosmolalityorificeorifice